chloroproMAZINE Hydrochloride Tablets 50 mg Recall: Foreign Material
chloroproMAZINE Hydrochloride Tablets, USP, 50 mg, 50 Tablets (5x10) unit dose carton, Rx only, Manufactured for: AvKare, Pulaski, TN, 38478, NDC…
What is the FDA recall status?
The FDA record lists this recall as ongoing. FDA enforcement data is not a live recall-lifecycle tracker. Follow the official instructions and check the agency notice or firm for current guidance.
Why was chloroproMAZINE Hydrochloride Tablets 50 mg recalled?
Presence of a foreign substance.
What should I do if I have this product?
Follow the firm and FDA instructions for the affected product. Contact the recalling firm for current guidance.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare your product with the product description and available lot, UPC or model codes below from the official FDA record to check whether it is covered by this recall. If an identifier is missing or unclear, check the complete official notice or contact the firm; an incomplete match here does not establish that your product is unaffected.
Full product description
chloroproMAZINE Hydrochloride Tablets, USP, 50 mg, 50 Tablets (5x10) unit dose carton, Rx only, Manufactured for: AvKare, Pulaski, TN, 38478, NDC 50268-164-15
Which lot codes, UPCs or models are affected?
Lot # 46824, Exp 9/30/25; 47171, Exp 12/31/25
- Agency record number
- D-0643-2025
- Product
- chloroproMAZINE Hydrochloride Tablets, USP, 50 mg, 50 Tablets (5x10) unit dose carton, Rx only, Manufactured for: AvKare, Pulaski, TN, 38478, NDC…
- Recalling firm
- AvKARE
- Quantity
- 1512 cartons
- Distribution
- USA Nationwide
- Recall started
- August 25, 2025
- Report date
- September 17, 2025
- Classification
- Class II
- Status
- Ongoing
- Agency
- FDA (drug)